Abstract
Stem cell therapies have emerged as one of the most promising approaches in regenerative medicine, offering unprecedented opportunities for drug development. These therapies are being explored for their potential in treating a variety of diseases, including neurological disorders, cardiovascular diseases, and metabolic conditions. By utilizing stem cells for drug discovery and development, researchers aim to create more effective treatments with fewer side effects. This article explores the applications of stem cell-based technologies in drug development, focusing on their role in disease modeling, toxicity testing, and personalized medicine. The article also examines the ethical concerns and regulatory challenges associated with the clinical use of stem cells in pharmaceutical development.
References
Ahmad, N. R. (2025). Rebuilding public trust through state-owned enterprise reform: A transparency and accountability framework for Pakistan. Punjab Sahulat Bazaars Authority. https://doi.org/10.52152/6q2p9250
Ahmad, N. R. (2025). Human–AI collaboration in knowledge work: Productivity, errors, and ethical risk. https://doi.org/10.52152/6q2p9250

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Dr. Sana Iqbal (Author)